Shah R, Wormald RPL. Glaucoma. Clinical Evidence 2011 [citado 11 Out 2012]; 06: 703. [Search date May 2010].

Sena DF, Ramchand K, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD006539. DOI: 10.1002/14651858.CD006539.pub2.

Burr J, Azuara‑Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews. In: The Cochrane Library, Issue 10, Art. No. CD004399. DOI: 10.1002/14651858.CD004399.pub2.

National Institute for Health and Clinical Excellence. NICE clinical guideline 85. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. Issue date: April 2009. [citado 01 Nov 2012]. Disponível em: http://www.nice.org.uk/nicemedia/live/12145/43839/43839.pdf

Osakidetza. Comité de Evaluación de Nuevos Medicamentos de Euskadi. Taflupost: Informe de Evaluación Nº 165/2010, Febrero, 2010. [citado 10 Out 2012]; Disponível em: http://www.osakidetza.euskadi.net/r85‑pkfarm02/es/contenidos/informacion/cevime_atencion_primaria/ es_cevime/r01hRedirectCont/

contenidos/informacion/cevime_nuevo_medicamento/es_nme/adjuntos/tafluprost_informe.pdf

Uusitalo H, Pillunat LE, Ropo A. Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open‑angle glaucoma and ocular hypertension: 24‑month results of a randomized, double‑masked phase III study. Acta Ophthalmol. 2010 Feb; 88(1): 12–19. doi: 10.1111/j.1755‑3768.2010.01862.x

Chabi A, Varma R, Tsai JC, Lupinacci R, Pigeon J, Baranak C, et al. Randomized Clinical Trial of the Efficacy and Safety of Preservative‑free Tafluprost and Timolol in Patients with Open‑Angle Glaucoma or Ocular Hypertension. Am J OphthalmoI 2012;153:1187‑1196. doi:1 O. 101 6/j.ajo.201 1.11.008.